Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …

For many years, luteinizing hormone-releasing hormone or gonadotropin-releasing
hormone (GnRH) analogs have been used to treat androgen or estrogen-dependent tumors …

Breast cancer is the most frequently diagnosed cancer and the leading cause of death by
cancer among women worldwide. The prognosis of the disease and patients' response to …

Background: Male breast cancer is rare. No information was available on how male breast
cancer patients (MBCPs) experience the health care they receive in Germany in a setting …

Background: Male breast cancer (MBC) is rare, and most previous studies limited their focus
on clinical aspects of the disease. Psychosocial implications and care needs of MBC …

Microwave-induced thermoacoustic imaging (MITAI) is an imaging technique with great
potential for detecting breast cancer at early stages. Thermoacoustic imaging (TAI) …

Male breast cancer (MBC) is a rare condition that accounts for 0.1% of all male cancers. Our
current evidence base for treatment is derived from female breast cancer (FBC) patients …

Ductal carcinoma in situ (DCIS) of male breast is a rare lesion, often associated with
invasive carcinoma. When the in situ component is present in pure form, histological grade …

Objective: To review presentation, diagnosis, treatment and prognosis of male breast
cancer. Method: A systematic review of the English language literature between 1990 and …

Male breast cancer (MBC) is a rare entity, underrepresented in population studies and
clinical trials, resulting in management of MBC to be informed by current research on female …